Literature DB >> 21122784

Changes in autism spectrum disorder prevalence in 4 areas of the United States.

Catherine Rice1, Joyce Nicholas, Jon Baio, Sydney Pettygrove, Li-Ching Lee, Kim Van Naarden Braun, Nancy Doernberg, Chris Cunniff, Craig Newschaffer, F John Meaney, Jane Charles, Anita Washington, Lydia King, Maria Kolotos, Kristen Mancilla, Cynthia A Mervis, Laura Carpenter, Marshalyn Yeargin-Allsopp.   

Abstract

BACKGROUND: We sought to describe autism spectrum disorder (ASD) population characteristics and changes in identified prevalence across 3 time periods.
METHODS: Children with a potential ASD were identified through records abstraction at multiple sources with clinician review based on Diagnostic and Statistical Manual (DSM-IV-TR) criteria. Multisite, population-based data from the Autism and Developmental Disabilities Monitoring (ADDM) Network were analyzed from areas of Arizona (AZ), Georgia (GA), Maryland (MD), and South Carolina (SC). Participants were 8-year-old children (born in 1992, 1994, or 1996) in 2000, 2002, or 2004 (and children born in 1988 residing in metropolitan Atlanta in 1996) who had been evaluated for a variety of developmental concerns at education and/or health sources.
RESULTS: From 2000 to 2004, the identified prevalence of the ASDs per 1,000 8-year-old children showed significant increases of 38% in GA and 72% in MD and a nonsignificant increase of 26% in AZ. ASD prevalence was relatively stable in SC with a nonsignificant decrease of 17%. Males had a higher identified prevalence of ASD in all years. Increases among racial, ethnic, and cognitive functioning subgroups varied by site and surveillance year. More children were classified with an ASD by community professionals over time, except in AZ.
CONCLUSIONS: There was a trend toward increase in identified ASD prevalence among 8-year-old children who met the surveillance case definition in 3 of the 4 study sites from 2000 to 2004. Some of the observed increases are due to improved ascertainment; however, a true increase in ASD symptoms cannot be ruled out. These data confirm that the prevalence of ASDs is undergoing significant change in some areas of the United States and that ASDs continue to be of urgent public health concern. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21122784     DOI: 10.1016/j.dhjo.2009.10.008

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  29 in total

1.  Completeness of case ascertainment for surveillance of autism spectrum disorders using the autism developmental disabilities monitoring network methodology.

Authors:  Joyce S Nicholas; Laura A Carpenter; Lydia B King; Walter Jenner; Amy Wahlquist; Sarah Logan; Jane M Charles
Journal:  Disabil Health J       Date:  2012-05-02       Impact factor: 2.554

2.  Maternal Pre-pregnancy Body Mass Index and Gestational Weight Gain in Relation to Autism Spectrum Disorder and other Developmental Disorders in Offspring.

Authors:  Gayle C Windham; Meredith Anderson; Kristen Lyall; Julie L Daniels; Tanja V E Kral; Lisa A Croen; Susan E Levy; Chyrise B Bradley; Christina Cordero; Lisa Young; Laura A Schieve
Journal:  Autism Res       Date:  2018-12-21       Impact factor: 5.216

3.  Examination of the Korean Modified Checklist of Autism in Toddlers: Item Response Theory.

Authors:  HyeKyeung Seung; Juye Ji; Soo-Jin Kim; Inkyung Sung; Young-Ah Youn; Gyunghun Hong; Hyeonjin Lee; Young Hwan Lee; Hyunsuk Lee; Hyun Kyung Youm
Journal:  J Autism Dev Disord       Date:  2015-09

4.  Brief report: independent validation of autism spectrum disorder case status in the Utah Autism and Developmental Disabilities Monitoring (ADDM) Network Site.

Authors:  Amanda V Bakian; Deborah A Bilder; Paul S Carbone; Tyler D Hunt; Brent Petersen; Catherine E Rice
Journal:  J Autism Dev Disord       Date:  2015-03

5.  Predictors of ascertainment of autism spectrum disorders across nine US communities.

Authors:  Sydney Pettygrove; Judith Pinborough-Zimmerman; F John Meaney; Kim Van Naarden Braun; Joyce Nicholas; Lisa Miller; Judith Miller; Catherine Rice
Journal:  J Autism Dev Disord       Date:  2013-08

6.  Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Kelly S Hunt; Elizabeth Garrett-Mayer; Jane Charles; Joyce S Nicholas
Journal:  J Autism Dev Disord       Date:  2014-11

7.  A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES).

Authors:  Eric Youngstrom; Lauren Kenworthy; Paul H Lipkin; Michael Goodman; Katherine Squibb; Donald R Mattison; Laura Gutermuth Anthony; Susan L Makris; Ambuja S Bale; Kathleen C Raffaele; Judy S LaKind
Journal:  Neurotoxicol Teratol       Date:  2011-02-18       Impact factor: 3.763

8.  DSM Criteria that Best Differentiate Intellectual Disability from Autism Spectrum Disorder.

Authors:  Anita L Pedersen; Sydney Pettygrove; Zhenqiang Lu; Jennifer Andrews; F John Meaney; Margaret Kurzius-Spencer; Li-Ching Lee; Maureen S Durkin; Christopher Cunniff
Journal:  Child Psychiatry Hum Dev       Date:  2017-08

9.  Brief Report: Prevalence of Self-injurious Behaviors among Children with Autism Spectrum Disorder-A Population-Based Study.

Authors:  Gnakub N Soke; Steven A Rosenberg; Richard F Hamman; Tasha Fingerlin; Cordelia Robinson; Laura Carpenter; Ellen Giarelli; Li-Ching Lee; Lisa D Wiggins; Maureen S Durkin; Carolyn DiGuiseppi
Journal:  J Autism Dev Disord       Date:  2016-11

10.  The changing prevalence of autism in three regions of Canada.

Authors:  Hélène Ouellette-Kuntz; Helen Coo; Miu Lam; Marlene M Breitenbach; Paula E Hennessey; Paulette D Jackman; M E Suzanne Lewis; Deborah Dewey; François P Bernier; Amy M Chung
Journal:  J Autism Dev Disord       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.